BTC $63,060.97 +0.09%
ETH $1,881.63 +0.02%
BNB $605.66 -0.70%
XRP $1.00 -0.27%
SOL $75.52 +0.22%
TRX $0.3308 -0.61%
DOGE $0.0697 -0.67%
ADA $0.1769 -2.15%
BCH $203.27 -1.20%
LINK $9.39 -1.19%
HYPE $56.96 +0.84%
AAVE $86.33 -0.58%
SUI $0.6758 -1.31%
XLM $0.1568 -1.23%
ZEC $486.65 -1.42%
BTC $63,060.97 +0.09%
ETH $1,881.63 +0.02%
BNB $605.66 -0.70%
XRP $1.00 -0.27%
SOL $75.52 +0.22%
TRX $0.3308 -0.61%
DOGE $0.0697 -0.67%
ADA $0.1769 -2.15%
BCH $203.27 -1.20%
LINK $9.39 -1.19%
HYPE $56.96 +0.84%
AAVE $86.33 -0.58%
SUI $0.6758 -1.31%
XLM $0.1568 -1.23%
ZEC $486.65 -1.42%

Public company Leap Therapeutics completes $58,888,888 private placement to initiate digital asset financial strategy

2025-10-09 19:13:53

ChainCatcher news, biotechnology company Leap Therapeutics (NASDAQ: LPTX) announced that it has completed the previously announced private placement led by Winklevoss Capital, raising $58,888,888 in cash to initiate its digital asset financial strategy.

Winklevoss Capital will provide funding and strategic support to help Leap build and execute its digital asset financial strategy.

app_icon
ChainCatcher Building the Web3 world with innovations.